ZYTrade Editor: It’s eventually going to happen (nobody knows when), but a post-pandemic economy is something for which we should position ourselves. But should we be thinking in terms of sectors, or might we widen our view to include other assets and even global...
ZYTrade Editor: The Federal Reserve has been saying for months that the fate of the US economy rests on our capacity to control viral spread. We now see the consequences of that failure. Vaccine progress has bolstered the market and investors’ “risk on” sentiment. Yet...
ZYTrade Editor: The Dow Jones Industrial Average hit a major milestone, reaching 30,000 for the first time ever. Yet global uncertainties prevail amid the pandemic. Does this milestone tell a story about US economic strength, or does it tell a story about the Federal...
A gap-down in Zoom stock was a big hit. But not as bad as it could have been due to swing trading rules. News of a coronavirus vaccine with 90% effectiveness came out on Nov. 9, and the results on stocks were widely different. It was good news for the biotechs...
A Confusing Technical Situation to Say the Least Here’s the skinny: we saw a potential double top [T1] and [T2] beginning September. That didn’t pan out and we knew it as soon as the downside breakout was followed by a high-volume buying surge. Now, we see a...
Recent Comments